Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Short-Term Debt issuances (2024 - 2025)

Coeptis Therapeutics Holdings has reported Short-Term Debt issuances over the past 2 years, most recently at -$218750.0 for Q1 2025.

  • Quarterly results put Short-Term Debt issuances at -$218750.0 for Q1 2025, up 23.91% from a year ago — trailing twelve months through Dec 2025 was -$218750.0 (up 66.4% YoY), and the annual figure for FY2025 was -$218750.0, up 66.4%.
  • Short-Term Debt issuances for Q1 2025 was -$218750.0 at Coeptis Therapeutics Holdings, down from -$63469.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for COEPW hit a ceiling of -$63469.0 in Q4 2024 and a floor of -$300000.0 in Q2 2024.